Tough Times for Biotechs
Tim Boreham
Abstract
Tim Boreham
Abstract
The market's aversion to speculative or complex investment propositions which has resulted in only six stocks managing to gain, while 102 declined by more than 10 per cent. A brief note on the companies, their business and the extent of loss or gain is provided.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The market's aversion to speculative or complex investment propositions which has resulted in only six stocks managing to gain, while 102 declined by more than 10 per cent. A brief note on the companies, their business and the extent of loss or gain is provided.
Key concepts: Project commissioning, Investment (military), Publishing, Economics, Business, Management, Political science, Law